Alan, a French health tech company, has successfully attracted a whopping $460 million investment from the Netherlands-based Prosus, elevating its valuation to an impressive $6.3 billion. This funding will significantly enhance Alan's growth efforts, promoting global expansion and driving innovation in AI-powered products. Additionally, the agreement grants Alan access to Prosus's Large Commerce Model, enabling improved health insurance and telehealth services in its existing markets.

Le néo-assureur santé français Alan lève 480 millions d'euros, dans le cadre de sa plus importante opération. Parmi ses ambitions: doubler sa présence à l'international.

La operación ha estado liderada por Prosus, con la participación de Teachers Venture Growth e Index Ventures. La firma ha acelerado su expansión en España